Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

Clinical trial NCT05441488 · SUSPENDED

Trial details

NCT number: NCT05441488
Sponsor: AB Science
Status: SUSPENDED
Phase: Phase 3
Study type: INTERVENTIONAL

Progressive Multiple Sclerosis

Start date: 2022-06-28
Primary completion: 2028-12-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.